Führungsteam

Mary Duseau

President

Mary kommt zu Molecular Devices mit mehr als 25 Jahren Erfahrung auf dem Life-Science-Markt, wo sie Positionen mit zunehmender Verantwortung in den Bereichen Vertrieb, Marketing und Business Management innehatte.

Bevor sie zu Molecular Devices kam, war sie Senior Vice President, Commercial Management bei Leica Biosystems, einem Danaher-Unternehmen. Vor ihrem Eintritt bei Danaher war sie CEO und Präsidentin von Roka Bioscience und davor Senior Vice President, Sales, für Andor Technologies und Global Vice President, Sales und Marketing, für PerkinElmer. Darüber hinaus war sie bei PerkinElmer Leiterin der Geschäftseinheit Imaging and Detection mit Schwerpunkt auf den Markt für Wirkstoffforschung und -entwicklung.

Sie hat einen Bachelor-Abschluss in Biochemie von der University of Massachusetts.

Hema Sundarraj

Chief Financial Officer

Hema Sundarraj serves as Chief Financial Officer of Molecular Devices, where she leads the global Finance organization to support strategic execution, accelerate growth, and strengthen financial and operational performance.

Most recently, she was Chief Financial Officer at Phenomenex, a Danaher operating company within the Life Sciences platform. In this role, she drove strong financial results and supported growth initiatives by enhancing working capital management, leading strategic investments, and advancing the company’s IT and eCommerce capabilities. She is also known for building high-performing, engaged teams.

Previously, Hema held senior finance leadership roles at Cepheid, Applied Materials, Nanometrics, Mattson Technology, and Sunpreme. Her experience spans public and private companies, as well as growth-stage organizations.

Hema holds an MBA in Finance and Marketing from XLRI Jamshedpur and is an inactive CPA in the state of California.

Lars Hartvig Kristiansen

Vice President, Product Innovation & Strategy

Lars Hartvig Kristiansen is Vice President of Product Innovation & Strategy, responsible for leading strategic initiatives, driving innovation, and overseeing the global product management team. He leads cross-functional efforts to grow the business through M&A, licensing, and partnerships, while guiding strategic planning and execution across the company.

Lars brings over a decade of experience in life sciences and management consulting. At Agilent Technologies, he held senior roles across strategy, operations, and M&A, including leading strategic growth initiatives for the $4B Life Sciences group and most recently serving as General Manager, running the Global Automation Solutions P&L. He holds Bachelor’s and Master’s degrees in Engineering from Aalborg University, with a focus on Technology Management and Supply Chain.

Dan Green

Vice President of Research and Development

Dan wurde im Juni 2020 zum Vice President of R&D ernannt. Zuvor diente er seit September 2018 als Senior Director of BioImaging R&D und seit April 2015 als Senior Director of Software. Er ist seit 1988 bei Molecular Devices und dessen Vorgängerunternehmen. Damals trat er der Universal Imaging Corporation als Softwareentwickler bei. Seither nahm er eine Vielzahl an technischen Positionen und Führungsrollen mit wachsender Verantwortung ein. Dan erhielt einen MS in Computer Science von der University of Illinois in Urbana-Champaign und einen BA von der Cornell University, Ithaca, NY.

Krishnapal Solanki

Vice President, DBS

Als Vice President – DBS beaufsichtigt Krishnapal alle Bemühungen zur kontinuierlichen Verbesserung – weltweit und für alle Funktionen. Krishnapal kam zu Molecular Devices im November 2021 und brachte mehr als 13 Jahre Erfahrung in der Leitung verschiedener Funktionen in 3 verschiedenen Danaher-Unternehmen mit.

Krishnapals Karriere bei Danaher begann als Kunde (Life-Science-Forschung), der später als Senior Field Service Engineer bei Leica Microsystems zu einem Danaher-Mitarbeiter wurde und verschiedene Positionen mit wachsender Verantwortung bekleidete, wie z. B. Regional Supervisor of Field Service Operations, Growth Manager for the Americas, Sr Manager Sales & Marketing bei Cepheid und zuletzt Director of DBS Innovation bei Molecular Devices. Krishnapal ist kompetent und zertifiziert für Tools zur Prozessverbesserung von Danaher wie DM/VM, Funnel Management und PSP und hat Kaizen-Workshops für funktionsübergreifende Teams in verschiedenen Danaher-Betrieben moderiert und geleitet. Sein Fachwissen umfasst die Installation und Wartung aller 3 DBS-Engines (Commercial, Innovation und Service), um das gesamte Unternehmenswachstum voranzutreiben. Krishnapal ist auch in DE&I-Aktivitäten involviert und war Members Engagement Lead bei Asian Descent + Friends ARG bei Danaher von 2021-2022.

Krishnapal hat einen Master of Science in Biomedical Engineering der UT Arlington und des SW Medical Center Dallas. Er hat einen Bachelor of Engineering in Biomedical Engineering aus Indien.

Lakshmi Sailaja Eleswarapu

Vice President, IT

As Vice President of IT for SCIEX, Molecular Devices, and Danaher Life Sciences, Lakshmi Eleswarapu champions global IT strategy, fostering technological innovation and organizational excellence. Her role extends to supporting the Danaher Life Sciences Innovation Group (LSIG) commercial team and contributing to the L1 team at Molecular Devices. Her tenure includes significant achievements in business transformation, M&A IT integrations, and diversity initiatives. Lakshmi's career spans 26 years in IT, with the last 16 years dedicated to Danaher, positioning her to drive future innovation and growth.

Lakshmi holds a Bachelor’s in Mathematics with Honors from SSSIHL University (India) and a Master’s in Computer Applications from Osmania University (India).

Ray Li

Vice President of Global Operations

Ray Li, Vice President of Global Operations, brings nearly 18 years of invaluable experience to Molecular Devices. Since joining in 2007 as a Manufacturing Engineer, Ray has held key roles including Production Manager, Production Manager & DBSL, Operations Manager, and Shanghai Plant General Manager, with Salzburg added to his responsibilities in 2022. In his new role, Ray will drive progress by enhancing operational efficiency and fostering innovation across global operations. Based in Shanghai, his extensive background and strategic vision make him a vital asset to our leadership team.

Tracy Clarke

Vice President of Service

Tracy Clarke, Vice President of Service, brings over 30 years of experience in the laboratory and medical industry to Molecular Devices. With a remarkable 17-year tenure at Leica Biosystems, Tracy excels in building high-performing teams, managing complex projects, and driving continuous improvement. As Senior Director of Service at Leica, she led a team of 210 professionals, managed a $96M P&L, and consistently drove customer satisfaction and revenue growth. Tracy is committed to enhancing our customers’ experience, building service capabilities, fostering strong cross-functional relationships, and promoting an inclusive culture.

Tracy Clarke, holds a master’s degree in Veterinary Medical Science and a Bachelor’s degree in Molecular Biology & Cell Science from the University of Florida.

Yang Shi

Vice President, Global Commercial

Yang Shi, Ph.D., MBA, is Vice President of Global Commercial at Molecular Devices, where he leads a worldwide team spanning Sales, Field Applications, Customer Service, and Sales Operations. He brings extensive commercial leadership experience from across Danaher, including roles at SCIEX, Phenomenex, and Integrated DNA Technologies (IDT).

Most recently, he served as Vice President of Americas Sales at IDT and previously as Vice President of Global Sales at Phenomenex. Earlier in his career, Yang advanced scientific innovation as a Senior Scientist with Waters Corporation, Thermo Fisher Scientific, and the Sanford Burnham Institute.

Yang holds a Ph.D. in Chemical Engineering from Yale University, an MBA from the University of Massachusetts–Amherst, and B.S. and M.S. degrees in Biochemical Engineering from Tianjin University.